Who Is Responsible When a Participant Experiences Research-Related Injury or Harm?

If the research harms a participant, who is responsible?

A participant is injured by a research procedure. The investigator conducted the procedure, the institution approved the study, a sponsor funded or initiated it, and an IRB or REC reviewed the protocol. Who is responsible for what happens next?

The tempting answer is to identify one party and call them “responsible.” Research oversight is rarely that simple. Responsibility can refer to several different things: protecting the participant immediately, providing or arranging appropriate medical attention, investigating what happened, reporting the event, modifying the study, paying treatment costs, providing compensation, or bearing legal liability.

Those responsibilities may fall on different parties. The applicable allocation depends on the study, contractual arrangements, institutional policy, regulatory framework, insurance or indemnification arrangements, and the law of the jurisdiction in which the research occurs.

Research-related harm can create several different responsibilities

“Who is responsible?” actually contains several different questions

Participant safety responsibility comes first

When a participant becomes ill or injured, the first practical responsibility is to protect the participant. The research team should follow the study's approved procedures for immediate safety, medical evaluation, referral, emergency response, and escalation as appropriate.

This should occur before arguments about whether the investigator, sponsor, institution, insurer, or another party will ultimately bear financial responsibility.

The broader procedure for responding when a participant becomes ill or injured during research therefore begins with care rather than liability analysis.

Ethical responsibility, operational responsibility, and legal liability are not the same thing

The word responsibility can obscure several distinct questions.

Answering one row does not automatically answer the others. The person responsible for submitting a safety report, for example, is not necessarily the party ultimately responsible for treatment costs.

The investigator has direct responsibilities toward participants

Investigators are responsible for conducting the research according to the approved protocol and applicable requirements and for protecting participants under their care. In clinical trials, ICH Good Clinical Practice assigns investigators responsibilities concerning medical care, participant safety, protocol compliance, and safety reporting.

When a significant event occurs, the investigator may need to ensure that appropriate medical care is available, assess the event, document it, communicate required information to the sponsor, and follow applicable reporting procedures.

Those responsibilities do not mean the investigator personally assumes every financial or legal consequence of the injury.

The sponsor has different safety responsibilities

In sponsored clinical research, the sponsor may have information and responsibilities extending across all participating sites. These can include ongoing safety evaluation, review of reported events, identification of emerging safety signals, regulatory reporting, communication of important new safety information, and decisions about protocol modifications or other protective measures.

An investigator may see one injury. The sponsor may see similar injuries at five sites. That broader view can create responsibilities that no individual investigator could perform alone.

This is similar to the distinction involved in deciding whether an adverse event is related to the research: site-level and aggregate assessments can involve different information and responsibilities.

The institution also has responsibilities

Research institutions may be responsible for establishing systems that support compliant and ethical research, including IRB or REC oversight, investigator support, safety procedures, contractual arrangements, insurance or indemnification structures, and processes for responding to research-related injuries.

The precise institutional responsibilities vary substantially across jurisdictions and organizations. Researchers should therefore know their own institution's policy rather than assuming that a familiar arrangement from another university or hospital applies locally.

The IRB or REC provides oversight, but that does not make it the treating or compensating party

An IRB or REC evaluates whether proposed research adequately protects participants and may review safety information, require modifications, suspend approval, or take other actions within its authority.

That oversight role should not be confused with providing clinical treatment or automatically accepting financial liability for an injury. The committee's responsibility is principally one of ethical and regulatory oversight rather than becoming the participant's medical provider or insurer.

Causation matters, but it does not answer every responsibility question

Determining that an injury is research-related can be important for reporting, treatment arrangements, compensation policies, insurance, and legal questions. Yet even a strong causal assessment does not automatically identify who must pay.

Conversely, uncertainty about causality should not delay appropriate participant care. A research team may need to respond to an event before the relatedness assessment is complete.

Payment for treatment is not the same as compensation for injury

These concepts are easy to collapse.

Medical treatment concerns care for the injury. Payment of medical expenses concerns who bears the cost of that care. Compensation may concern additional financial redress for injury or its consequences. Legal damages involve yet another question governed by applicable law.

A study may have arrangements for one without automatically providing all of the others.

Under the U.S. HHS informed-consent requirements, research involving more than minimal risk must explain whether compensation and whether medical treatments are available if injury occurs and, if so, what they consist of or where further information may be obtained. OHRP's guidance emphasizes that these explanations should be consistent with sponsor and institutional policies.

Consent cannot simply make the participant waive legal rights

Researchers sometimes assume that an injury clause can solve institutional responsibility by having participants accept all consequences of participation. U.S. HHS protections do not permit that approach.

OHRP states that informed consent may not contain exculpatory language through which participants waive or appear to waive legal rights or release or appear to release investigators, sponsors, institutions, or their agents from liability for negligence.

Participants should know whom to contact if injury occurs

Responsibility should not be so administratively complicated that an injured participant has no idea whom to call.

HHS informed-consent requirements include an explanation of whom participants should contact with questions about the research and their rights, as well as whom to contact in the event of research-related injury. OHRP further notes that questions concerning research-related injury may appropriately be directed to an informed body outside the immediate research team, depending on institutional arrangements.

Researchers should therefore know the injury contact pathway themselves. Handing an injured participant a consent form and asking them to decipher institutional responsibility is not much of a response system.

A serious incident can create responsibilities toward future participants too

Responsibility does not end with responding to the injured individual. If the event reveals a previously underestimated hazard, the investigator, sponsor, institution, IRB or REC, or another oversight body may need to act to protect people who have not yet experienced harm.

Possible actions can include additional monitoring, revised procedures, new consent information, temporary suspension of an activity, or broader study modification. The appropriate response depends on the nature of the safety signal and the authority of each party.

This becomes especially important when deciding whether a participant-safety problem requires changes to the entire study.

A participant is injured by a study-specific procedure

One injury can therefore generate several legitimate answers to “Who is responsible?” because the question changes depending on the responsibility being discussed.

Common mistakes about responsibility for research-related harm

Know the injury pathway before anyone is injured

Researchers should also know exactly what participants have been told about treatment and compensation for research-related harm. The consent process should not leave the first meaningful discussion of those arrangements until after someone is injured.

Before enrolling participants in research with meaningful injury risk

Frequently asked questions about responsibility for research-related injury

Responsibility for harm is shared across different functions

How to Cite This Guide

This guide is intended to be read, shared, and used in research, teaching, and academic work. If you draw on its ideas, explanations, or other content, please acknowledge the source by citing the guide. Doing so gives appropriate credit and helps your readers locate the original resource.